Acumen Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $6.6M |
| Jun 2020 | — | — | $3.2M |
| Sep 2020 | — | — | $2.0M |
| Dec 2020 | $6.4M | $44.4M | $43.8M |
| Mar 2021 | — | — | $41.4M |
| Jun 2021 | $4.5M | $72.9M | $68.8M |
| Sep 2021 | $1.5M | $234.8M | $135.8M |
| Dec 2021 | $5.1M | $230.3M | $122.2M |
| Mar 2022 | $4.0M | $220.1M | $108.8M |
| Jun 2022 | $5.2M | $211.7M | $111.1M |
| Sep 2022 | $6.6M | $203.3M | $157.5M |
| Dec 2022 | $7.8M | $196.6M | $130.1M |
| Mar 2023 | $8.8M | $187.9M | $78.0M |
| Jun 2023 | $8.5M | $177.4M | $77.2M |
| Sep 2023 | $6.1M | $286.4M | $94.9M |
| Dec 2023 | $43.2M | $310.1M | $66.9M |
| Mar 2024 | $38.9M | $301.0M | $46.9M |
| Jun 2024 | $45.0M | $288.9M | $68.0M |
| Sep 2024 | $49.8M | $267.0M | $33.2M |
| Dec 2024 | $57.2M | $239.0M | $35.6M |
| Mar 2025 | $49.0M | $204.5M | $30.2M |
| Jun 2025 | $54.8M | $171.9M | $36.8M |
| Sep 2025 | $49.0M | $142.2M | $46.8M |
| Dec 2025 | $52.4M | $122.8M | $54.0M |
| Mar 2026 | $46.2M | $133.6M | $51.8M |
| Jun 2026 | $58.7M | $116.0M | $59.4M |